Factors Associated with Remaining on Initial Randomized Efavirenz-containing Regimens in the AIDS Clinical Trials Group

OBJECTIVE: Efavirenz (EFV) plus 2 nucleoside reverse transcriptase inhibitors (NRTIs) is a recommended initial antiretroviral (ARV) regimen. Understanding characteristics related to EFV success is clinically useful. DESIGN: Data from 2,220 ARV-naïve participants randomized to EFV + 2/3 NRTIs in 4 AC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Smurzynski, Marlene, Wu, Kunling, Schouten, Jeffrey T., Lok, Judith J., Bosch, Ronald J., Taiwo, Babafemi, Johnson, Victoria Anne, Collier, Ann C.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4204654/
https://ncbi.nlm.nih.gov/pubmed/23925417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0b013e328361645f
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados